Heghine Khachatryan: Intracranial Hemorrhage in Leukemia – Beyond Thrombocytopenia
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared RPTH Journal’s post on LinkedIn:
“Intracranial hemorrhage in leukemia – beyond thrombocytopenia
Emerging pathology data highlight a critical mechanism: leukemic cell infiltration of cerebral vessels leading to direct vascular injury.
Key mediators such as cathepsin G and VEGF appear to drive endothelial damage, meningeal invasion, and ultimately bleeding.
Takeaway:
Intracranial hemorrhage in leukemia is not purely a coagulation defect – it is also a vascular disease driven by leukemic biology.”
RPTH Journal shared a post on LinkedIn about a recent article by Toshihiro Gi et al., published in RPTH Journal, adding:
“Intracranial hemorrhage in leukemia: what do autopsy findings reveal about the underlying mechanisms?
Intracranial haemorrhage (ICH) is one of the most devastating complications of leukemia, yet the mechanisms driving cerebral vascular injury and CNS involvement remain poorly understood.
A new autopsy-based study in RPTH Journal sheds light on this critical question.
Key findings from 37 leukemia cases and 20 matched controls:
- ICH was identified in 68% of leukemia cases, with fatal brain herniation in 40%
- CNS involvement was observed in 54% of cases, often without a prior clinical diagnosis
- Leukemic cell infiltration of meninges and vascular walls was frequently associated with structural changes in smooth muscle cells and adventitial collagen
- VEGF was highly expressed in leukemia cells and linked to meningeal invasion
- Cathepsin G, predominantly expressed in myeloid leukemia, was associated with cerebral vascular damage
The identification of VEGF and cathepsin G as potential markers of CNS invasion and vascular injury opens promising avenues for earlier detection and targeted intervention in leukemia-associated ICH.”
Title: Cathepsin G is associated with cerebral vascular injury in myeloid leukemia: a pathologic insight into intracranial hemorrhage
Authors: Toshihiro Gi, Kaiyou Kai, Kotaro Shide, Eriko Nakamura, Nobuyuki Oguri, Murasaki Aman, Kazunari Maekawa, Sayaka Moriguchi-Goto, Michikazu Nakai, Kazuya Shimoda, Yohei Hisada, Atsushi Yamashita

Other posts featuring Heghine Khachatryan and RPTH Journal on Hemostasis Today.
-
Apr 27, 2026, 15:56Marc Carrier: Supporting Thrombosis Canada in My Final Year as President
-
Apr 27, 2026, 15:52Tagreed Alkaltham։ You Think Eligibility Is About You… It’s Not
-
Apr 27, 2026, 15:52Emma Gasson: Top Abstract Oral Presentation at BSH 2026 on Cancer-Associated Thrombosis Microfluidics
-
Apr 27, 2026, 15:48Elliot Tapper: Continuing Anticoagulation Improves PVT Outcomes During Banding
-
Apr 27, 2026, 15:44Crisanto Torres: Early Plasma Administration Maximizes Survival in Traumatic Intracranial Hemorrhage
-
Apr 27, 2026, 15:38Key Insights from ESHMPN 26 on Advances in MPN Management – ESH
-
Apr 27, 2026, 15:30Shahid Gilani: Risk of Thrombosis in Central Venous Catheters in Cancer Patients
-
Apr 27, 2026, 15:24Anirban Sen Gupta: PlateChek Microsensor for Rapid Coagulation Testing
-
Apr 27, 2026, 15:04Tareq Abadl։ Why You Should Never Separate Serum Before Clotting Is Complete